-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Jil/SAnC2lIMykkb5kOzLosBsCTAHh0Gn/AQbtavkTHfHN6Clus6+zH+BFBOBnD/ DJcZ7AoDBjx3BQ63Ku6feA== 0001021890-06-000012.txt : 20060119 0001021890-06-000012.hdr.sgml : 20060119 20060118182832 ACCESSION NUMBER: 0001021890-06-000012 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060117 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20060119 DATE AS OF CHANGE: 20060118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LIFELINE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841097796 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30489 FILM NUMBER: 06536496 BUSINESS ADDRESS: STREET 1: 6400 SOUTH FIDDLER STREET 2: SUITE 1750 CITY: ENGLEWOOD STATE: CO ZIP: 80111 BUSINESS PHONE: 720-488-1711 MAIL ADDRESS: STREET 1: 6400 SOUTH FIDDLER STREET 2: SUITE 1750 CITY: ENGLEWOOD STATE: CO ZIP: 80111 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 8-K 1 lifeline116068k.htm JANUARY 17, 2006 FORM 8-K Lifeline Therapeutics, Inc. January 17, 2006 Form 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): January 17, 2006

Lifeline Therapeutics, Inc.
(Exact name of registrant as specified in its charter)

Colorado      
 000-30489
 84-1097796
(State or other jurisdiction   (Commission File Number)   (IRS Employer Identification No.)  
         of incorporation)       

6400 South Fiddler’s Green Circle, Suite 1970, Englewood, CO 80111
(Address of principal executive offices)             (Zip Code)

Registrant’s telephone number, including area code:  (720) 488-1711

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[    ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[    ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[    ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[    ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 7.01 Regulation FD Disclosure

     From January 17, 2006 until January 20, 2006, in connection with the release of the article in the scientific journal Free Radical Biology & Medicine (Jan. 15, 2006) entitled “The induction of human superoxide dismutase and catalase in vivo: A fundamentally new approach to antioxidant therapy,” Stephen K. Onody, Chief Executive Officer of Lifeline Therapeutics, Inc. (the “Company”), and Joe M. McCord, Ph.D., Director of Science for the Company, are meeting with members of the investment community, and will be guests on various radio interviews.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: January 18, 2006

 

LIFELINE THERAPEUTICS, INC.


By:    /s/ Stephen K. Onody                                 
     Stephen K. Onody
     Chief Executive Officer


2

-----END PRIVACY-ENHANCED MESSAGE-----